GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)
GLAX.NS on National Stock Exchange of India
2,273.50INR
24 May 2013
2,273.50INR
24 May 2013
Price Change (% chg)
Rs-8.85 (-0.39%)
Rs-8.85 (-0.39%)
Prev Close
Rs2,282.35
Rs2,282.35
Open
Rs2,267.00
Rs2,267.00
Day's High
Rs2,291.95
Rs2,291.95
Day's Low
Rs2,259.95
Rs2,259.95
Volume
2,139
2,139
Avg. Vol
23,236
23,236
52-wk High
Rs2,522.00
Rs2,522.00
52-wk Low
Rs1,801.20
Rs1,801.20
About
GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company’s product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, cardiovascular disease and respiratory diseases. It also offers... (more)
Overall
| Beta: | 0.20 |
| Market Cap (Mil.): | Rs192,572.30 |
| Shares Outstanding (Mil.): | 84.70 |
| Dividend: | 50.00 |
| Yield (%): | 2.20 |
Financials
| GLAX.NS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 58.79 | 34.04 | 34.30 |
| EPS (TTM): | 38.67 | -- | -- |
| ROI: | -- | 19.04 | 18.43 |
| ROE: | -- | 19.78 | 19.30 |
UPDATE 5-GSK to spend $1 bln to lift stakes in India, Nigeria units
* GSK Consumer Healthcare shares hit record high in India
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

